Intercell AG was founded as a spin-off of the Campus Vienna Biocentre in 1998 and raised total capital of EUR 100 million. Intercell now employs 130 people. With 2 products at advanced stages of clinical development and five other products at the development stage, Intercell is well represented in its target markets.
The basic requirements of Intercell AG were to store both project and cost centre data. A further requirement was to show all results (profit & loss, cash flow statement, balance sheet) according to US-GAAP. The unique form in which the software was implemented permits data for each cost centre and project to be imported directly from the previous system. Costs which cannot be directly allocated are apportioned in Professional Planner so that informative reports can be forwarded to those responsible for cost centres and projects. Furthermore, all reports for management and investors are prepared from the same database using an automated process.